Michael S. Balzer
banner
ms-balzer.bsky.social
Michael S. Balzer
@ms-balzer.bsky.social
MD FASN | Nephrologist = kidney doc | #PeritonealDialysis aficionado | #ClinicianScientist @ChariteBerlin | Ex-editorial fellow @JASN | #SingleCell | Determined to understand adaptation to kidney disease | #ERCStG
Reposted by Michael S. Balzer
Keep Calm & Carry On
Inhibiting RAS 👑

#Kidneywk #Nephjc

👉 www.nephjc.com/news/stopacei
👉 www.nephjc.com/news/aceing-...
November 8, 2025 at 7:29 PM
👏Huge congratulations to my fantastic mentor @ksusztak.bsky.social for receiving the 2025 ASN Homer Smith award.
Katalin Susztak accepting the Homer W. Smith Award. #KidneyWk
November 7, 2025 at 2:37 PM
👏Fantastic to see @cetinsz.bsky.social from our team presenting insights into #single-cell transcriptomic patterns distinguishing recovery from non-recovery after #AKI. Exciting 🧪 at #KidneyWk Houston, TX! #MedSky #NephSky
November 6, 2025 at 11:24 PM
❓Do we finally have a nodular sclerosis mouse model for DKD? 🔥Tour-de-force #kidneywk talk by @linkermannlab.bsky.social suggests so. 🧪 #NephSky #MedSky
November 6, 2025 at 9:37 PM
Reposted by Michael S. Balzer
Cell Decoder: decoding cell identity with multi-scale explainable deep learning. #SingleCellOmics #CellCharacterization #GenomeBiology 🧪🧬 🖥️
genomebiology.biomedcentral.com/articles/10....
October 27, 2025 at 9:31 AM
Reposted by Michael S. Balzer
🚀 Curious about #SpatialOmics? Want to master spatial omics data analysis using #Rstats and @bioconductor.bsky.social ?

🔥 Registrations are now OPEN for the 3rd edition of our hands-on course with @stemang.bsky.social !

📅 Save the dates: 18–20 May 2026
www.physalia-courses.org/courses-work...
spatial Omics in R/Bioconductor
18-20 May 2026 To foster international participation, this course will be held online
www.physalia-courses.org
October 7, 2025 at 3:05 PM
🚀Excited to announce that I’ve been awarded an @erc.europa.eu StG to advance research how kidneys heal themselves — a paradigm shift for understanding & treating #kidneydisease 🫘🩺🧬🧪
👉ERC press release: t.ly/CBxwB
👉Charité press release: t.ly/SR_Wn
#ERCStG #HorizonEU #KidneyResearch #NephSky #MedSky
The ERC awards €761m to the next generation of scientists in Europe
The European Research Council (ERC) has selected 478 early-career researchers across Europe to receive this year’s Starting Grants. With a total funding of €761 million, these grants support excellent...
t.ly
September 4, 2025 at 11:21 AM
Reposted by Michael S. Balzer
📑 Need something to read this weekend? If so, you're in luck!

"Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules" fueled by #KPMP investigators is hot off the press today @science.org

www.science.org/doi/10.1126/...
Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules
The interplay in expression of the stem cell markers THY1 and PROM1 in kidney proximal tubules marks the timeline of disease.
www.science.org
August 15, 2025 at 8:15 PM
🔥 Huge congrats to @ksusztak.bsky.social & team on a landmark @natgenet.nature.com paper!
🚶‍♂️🐁🐀Cross-species 🫘kidney pathway dysregulation via #singlecell functional profiling of individual samples — opening new therapeutic avenues.
🔗 www.nature.com/articles/s41...
🧪 #NephSky #MedSky
August 8, 2025 at 8:08 AM
🔥Paper alert @nature.com. Fantastic 🧪resource for the renal 🫘 community! #NephSky #MedSky

Congrats @puellesv.bsky.social lab and team!
#HotFromThePress !!

What if instead of analyzing 4-6 pathology markers you could check >100 in the *same* sample?

@maltekuehl.com & co @puellesv.bsky.social lab introduce #PathoPlex, method that could even predict disease

Full www.nature.com/articles/s41...
@focalplane.bsky.social @nature.com 🧪🔬
July 20, 2025 at 12:06 PM
Reposted by Michael S. Balzer
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy

doi.org/10.1016/j.kint.2025.05.028

#OpenAccess #IgAN #felzartamab #IgANephropathy
July 7, 2025 at 3:16 PM
Reposted by Michael S. Balzer
Simon Davies kicking off day 2 of the 1st International Meeting on
Cellular and Molecular Peritonial Dialysis Research in Kiel.
July 5, 2025 at 7:13 AM
👏Congrats to the KidneyCure 2025 Grant Recipients! 🫘🧪
@asnpublications.bsky.social #NephSky #MedSky
July 1, 2025 at 2:52 PM
Reposted by Michael S. Balzer
In the latest video in our partnership with @glaucomflecken.bsky.social, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free: nej.md/DrG19
June 21, 2025 at 10:53 AM
Reposted by Michael S. Balzer
The Fellowship Program is one of the ISPD’s key instruments to strengthen global PD expertise through hands-on learning and knowledge exchange.

Learn more about the results of our first call for applications in 2025 and the new application modality for teams Doctor-Nurse.

buff.ly/7XjuPCM
ISPD Fellowship results - 1st call 2025 - International Society for Peritoneal Dialysis
The Fellowship Program is one of the ISPD’s key programs to strengthen global PD expertise through hands-on learning and knowledge exchange. For the first round of 2025, we received 17…
buff.ly
June 22, 2025 at 7:13 AM
Reposted by Michael S. Balzer
In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology
June 5, 2025 at 9:45 AM
🎉🎈Congrats to all ASN 2025 🏆Lifetime & Midcareer awardees!

Well-deserved, @ksusztak.bsky.social @rkramann.bsky.social @genetickidneydoc.bsky.social, you are on 🔥!!!
#NephSky, #MedSky, #ERA25
June 4, 2025 at 4:47 PM
Reposted by Michael S. Balzer
In the May 2025 #ASNKidneyNews Policy Update, explore recent new and existing policy actions from ASN Advocacy that benefit physicians, patients, and researchers. bit.ly/KN1705-16
May 31, 2025 at 5:29 PM
Reposted by Michael S. Balzer
The effect of disappearing data from US public health

#OpenAccess viewpoint in @thelancet.com

www.thelancet.com/journals/lan...

#MedSky #EpiSky
May 27, 2025 at 2:24 PM
📣Attention #NephSky #MedSky!
Inaugural #PeritonealDialysis 🧪research meeting incoming:

"1st International Meeting on Cellular & Molecular #PD Research"
📆July 4-5, 2025 @The Nucleus, 🛳️Kiel, Germany
🔗Program & registration: www.pdmeeting.skip-sh.de
👫@ispd.org @dgfn.bsky.social ERA/EDTA
May 18, 2025 at 6:59 AM
Reposted by Michael S. Balzer
⏳ Two Weeks Left! Submit your research abstract or case report for #KidneyWk 2025 by Wednesday, May 21, at 2:00 p.m. EDT.

Take the stage at the world’s premier nephrology meeting and share your work with 12,000+ kidney professionals.

Submit now: asn.kdny.info/SwgN50VMhU6
May 7, 2025 at 8:55 PM
Reposted by Michael S. Balzer
May 5, 2025 at 4:33 PM
Reposted by Michael S. Balzer
A new spatial transcriptomics approach eliminates the need for time-intensive imaging with specialized equipment, making the technique accessible to more researchers around the world. @naturebiotech.bsky.social
Scientists have developed a way to scale up spatial genomics and lower costs
A new computational approach eliminates time-intensive imaging, enabling high-resolution spatial mapping of gene expression in tissue.
broad.io
April 3, 2025 at 1:14 PM
Some light reading on how relevant the kidney is: Michelangelo: 🎨Art, 🧪anatomy, and the 🫘kidney
#NephSky #MedSky
@kidneyint.bsky.social
🔗 www.kidney-international.org/article/S008...
Michelangelo: Art, anatomy, and the kidney
Michelangelo: Art, anatomy, and the kidney. Michelangelo (1475–1564) had a life-long interest in anatomy that began with his participation in public dissections in his early teens, when he joined the ...
www.kidney-international.org
March 31, 2025 at 8:44 AM